Ad is loading...
MAIHX
Price
$16.25
Change
+$0.01 (+0.06%)
Updated
Nov 15 closing price
VTIAX
Price
$32.41
Change
-$0.16 (-0.49%)
Updated
Nov 15 closing price
Ad is loading...

MAIHX vs VTIAX

Header iconMAIHX vs VTIAX Comparison
Open Charts MAIHX vs VTIAXBanner chart's image
Morgan Stanley Inst Passport ovrs eq IR
Price$16.25
Change+$0.01 (+0.06%)
VolumeN/A
CapitalizationN/A
Vanguard Total Intl Stock Index Admiral
Price$32.41
Change-$0.16 (-0.49%)
VolumeN/A
CapitalizationN/A
MAIHX vs VTIAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MAIHX vs. VTIAX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MAIHX is a Sell and VTIAX is a Buy.

FUNDAMENTALS
Fundamentals
VTIAX has more cash in the bank: 442B vs. MAIHX (142M). VTIAX pays higher dividends than MAIHX: VTIAX (3.26) vs MAIHX (1.63). MAIHX was incepted earlier than VTIAX: MAIHX (5 years) vs VTIAX (14 years). MAIHX is a more actively managed with annual turnover of: 14.00 vs. VTIAX (4.00). VTIAX has a lower initial minimum investment than MAIHX: VTIAX (3000) vs MAIHX (5000000). MAIHX annual gain was more profitable for investors over the last year : 13.11 vs. VTIAX (10.93). MAIHX return over 5 years is better than : 22.03 vs. VTIAX (15.88).
MAIHXVTIAXMAIHX / VTIAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence5 years14 years-
Gain YTD8.3334.536184%
Front LoadN/AN/A-
Min. Initial Investment50000003000166,667%
Min. Initial Investment IRAN/AN/A-
Net Assets142M442B0%
Annual Yield % from dividends1.633.2650%
Returns for 1 year13.1110.93120%
Returns for 3 years-19.08-5.89324%
Returns for 5 years22.0315.88139%
Returns for 10 yearsN/A31.47-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LAD371.06-1.55
-0.42%
Lithia Motors
BKE47.92-0.82
-1.68%
Buckle (The)
YMAB11.14-0.45
-3.88%
Y-mAbs Therapeutics
ORMP2.23-0.11
-4.50%
Oramed Pharmaceuticals
CYCC0.37-0.02
-4.91%
Cyclacel Pharmaceuticals